A HIV phenotypic assay that accurately quantifies susceptibility to protease, reverse transcriptase and integrase inhibitors, as well as future RNase H and maturation inhibitors in a single test.

  • Novel yeast recombination system permits greater representation of viral quasi species compared to other cloning methods
  • Broad system allows the cloning of viral fragments from different HIV-1 subtypes
  • HIV phenotypic profile provided for over 20 antiretroviral drugs targeting gag and pol genes
  • Ability to include additional antiretroviral drugs on demand
  • Turn-around time of 20 to 25 days

Make an Appointment

Schedule your appointment with a specialist at University Hospitals.
1-866-UH4-CARE (1-866-844-2273)

More Scheduling Options

Need to Refer a Patient?

Click here for Patient Referrals

Browse Services A-Z

Maps and Directions

Click here for directions